Benzodiazepine Market Research Report - Forecast to 2030

Benzodiazepine Market Information, By Applications (anxiety, insomnia, agitation, seizures, muscle spasms, alcohol withdrawal symptoms), By time of action (Long acting, Short acting), - Forecast Till 2030

ID: MRFR/Pharma/1674-HCR | 85 Pages | Published By Rahul Gotadki on April 2023         

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Benzodiazepine Market, by Application

5.1 Introduction

5.1.1 Anxiety

5.1.2 Insomnia

5.1.3 Agitation

5.1.4 Seizures

5.1.5 Muscle spasms

5.1.6 Alcohol withdrawal symptoms

5.1.7 Anaesthesia supplements

7 Global Benzodiazepine Market, by Time of Action

7.1 Introduction

7.1.1 Long acting

7.1.3 Short acting

8 Global Benzodiazepine Market, by Regions

8.1 Introduction

8.1.1 Americas

8.1.1.1 North America

8.1.1.2 South America

8.1.2 Europe

8.1.2.1 Germany

8.1.2.2 France

8.1.2.3 UK

8.1.2.4 Italy

8.1.2.5 Spain

8.1.2.6 Rest of Europe

8.1.3 Asia Pacific

8.1.3.1 Japan

8.1.3.2 China

8.1.3.3 India

8.1.3.4 Republic of Korea

8.1.3.5 Rest of Asia Pacific

8.1.4 Middle East & Africa

9 Company Landscape

9.1 Introduction

9.1.1 Mergers Acquisitions

9.1.2 Collaborations

9.1.3 Release/New Product Launches

9.1.4 Other (Expansion, Updates, Partnership)

10 Company Profile

10.1 AstraZeneca plc

10.1.1 Company Overview

10.1.2 Product/Business Segment Overview

10.1.3 Financials

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Eli Lilly and Company

10.2.1 Overview

10.2.2 Product/Business Segment Overview

10.2.3 Financials

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 GlaxoSmithKline plc

10.3.1 Overview

10.3.2 Product/Business Segment Overview

10.3.3 Financials

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.4 Pfizer, Inc.

10.4.1 Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financials

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.5 Sanofi S.A.

10.5.1 Overview

10.5.2 Product/Business Segment Overview

10.5.3 Financials

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Merck & Co., Inc.

10.6.1 Overview

10.6.2 Product/Business Segment Overview

10.6.3 Financials

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Others

11 Appendix
List of Tables

TABLE 1 GLOBAL BENZODIAZEPINE MARKET, 2020-2027 (USD MILLION)

TABLE 2 GLOBAL BENZODIAZEPINE MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL BENZODIAZEPINE MARKET, BY TIME OF ACTION, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL BENZODIAZEPINE MARKET, BY REGION, 2020-2027 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL BENZODIAZEPINE MARKET, BY APPLICATION

FIGURE 4 GLOBAL BENZODIAZEPINE MARKET, BY TIME OF ACTION

FIGURE 5 GLOBAL BENZODIAZEPINE MARKET, BY REGION

FIGURE 6 GLOBAL BENZODIAZEPINE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)